Schott
SCHOTT Poonawalla manufactures Type I borosilicate glass primary pharmaceutical packaging — syringes, vials, cartridges, and ampoules — for drug manufacturers, biotech companies, and CDMOs across India and global regulated markets.
- Company typePrivate
- Founded1990
- HeadquartersMumbai, India
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Schott does
SCHOTT Poonawalla Private Limited, incorporated in 1994 and headquartered in Mumbai, manufactures tubular pharmaceutical glass packaging at three GMP-compliant production sites in India (Jambusar and Umarsadi in Gujarat, Baddi in Himachal Pradesh), employing more than 2,000 staff. The company is a joint venture between SCHOTT Pharma AG & Co. KGaA (Germany) — part of the SCHOTT AG group — and Indian partners, drawing on SCHOTT Pharma's globally registered FIOLAX® Type I borosilicate glass tubing and a portfolio of proprietary brands including Safepac™ ready-to-use (RTU) syringes, vials, and cartridges, CosmetiQ high-quality vials, Dual Chamber prefilled syringes, and Anti-Counterfeiting ampoules with light-emitting particle authentication.
The product portfolio spans four primary packaging formats — syringes, cartridges, vials, and ampoules — available in both bulk non-sterile configurations and pre-sterilized ready-to-use (RTU) nest-and-tub or tray formats, with regulatory certifications including ISO 15378-2017 across all three sites, ISO 13485-2016 at Umarsadi, and Drug Master Files registered for China, USA, and Canada. The company also provides professional services including DMF preparation and regulatory affairs support, analytical testing, and fill-and-finish process optimization.
Revenue is generated primarily through hardware sales of primary packaging containers to pharmaceutical manufacturers, biotech companies, and Contract Development and Manufacturing Organizations (CDMOs), with RTU sterile formats commanding premium pricing and ancillary regulatory services fees layered on. The go-to-market is sales-led and inquiry-driven, with direct enterprise engagement via the website (quote, sample, and technical inquiry forms) supported by paid digital marketing across Google, LinkedIn, Microsoft, and Meta channels, and customer relationship management through Microsoft Dynamics 365.
Schott firmographics
Firmographics- Name
- Schott
- Legal name
- SCHOTT Poonawalla Private Limited
- Website
- https://schott-poonawalla.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- SCHOTT Poonawalla manufactures Type I borosilicate glass primary pharmaceutical packaging — syringes, vials, cartridges, and ampoules — for drug manufacturers, biotech companies, and CDMOs across India and global regulated markets.
- Ownership category
- akta.pro rank
Schott industry classification
Industry- Product category
- Pharmaceutical Primary Packaging
- NAICS
- Glass Container Manufacturing (327213)
- SIC
- Glass Containers (3221)
- akta.pro primary industry
- Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB)
- akta.pro secondary industries
- Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB), Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features) (IMALAIAJ)
Keywords
Where Schott is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
Schott business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical Glass Container Sales: Sale of primary packaging solutions including prefillable syringes, cartridges, vials, and ampoules made from Type I borosilicate glass. Revenue is generated through product sales to pharmaceutical and biotech companies, with ready-to-use (RTU) sterile formats commanding premium pricing.
- Regulatory Services: Regulatory affairs support including Drug Master File (DMF) preparation, registration, and maintenance for China, USA, and Canada markets. Revenue generated through service fees supporting drug product and medical device registrations.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Schott product offering
Product offeringCore offering
SCHOTT Poonawalla designs and manufactures primary pharmaceutical packaging made from Type I borosilicate glass (FIOLAX®) for injectable drugs, biologics, and vaccines. The portfolio includes ready-to-use (Safepac™) and bulk (StandardLine) vials, prefillable syringes (including dual-chamber), cartridges, and ampoules, complemented by regulatory services such as Drug Master File preparation for China, USA, and Canada.
Product overview
SCHOTT Poonawalla offers a comprehensive portfolio of tubular glass primary pharmaceutical packaging products manufactured in India, all made using high quality Type I Borosilicate Glass (FIOLAX®). The product range includes Safepac™ prefillable syringes (standard and dual chamber), Safepac™ cartridges and vials, StandardLine cartridges, Standard and CosmetiQ vials, and Standard and Anti-Counterfeiting ampoules. Products are available in both bulk (non-sterile) and ready-to-use (RTU) pre-sterilized configurations. The portfolio serves the pharmaceutical and biotech industries with containers for injectable drugs, supporting applications from vaccines and biologics to insulin delivery and emergency medications. SCHOTT Poonawalla also provides regulatory services including Drug Master File support and analytical services through its joint venture with SCHOTT Pharma.
Differentiator
Problem solved
Functional benefit
Products and services
- Safepac™ Glass Syringes Ready-to-use prefillable glass syringes made from FIOLAX® Type I borosilicate glass, designed for high-speed fill-and-finish processing of injectable drugs, biologics, and vaccines. Available in 0.5ml–10ml volumes with staked needle, Luer Cone, and Luer Lock closure systems.
- Safepac™ Dual Chamber Syringes Specialized drug delivery system with two chambers separated by a plunger and bypass for reconstituting and administering sensitive drugs (liquid-liquid or liquid-lyophilized) at point of use. Made from FIOLAX® Type I borosilicate glass in 3ml–10ml volumes.
- Safepac™ Cartridges High-quality ready-to-use (RTU) medical cartridge system made from FIOLAX® clear Type I borosilicate glass, designed for hand-held injection devices such as pens and auto-injectors used with biologic drugs including insulin and GLP-1.
- Safepac™ Vials Pre-washed and pre-sterilized ready-to-use (RTU) glass vials made from gold-standard FIOLAX® borosilicate glass. Available in tray, cup nest, and clip nest formats from 2R–100R for maximum flexibility at filling lines.
- StandardLine Cartridges (Bulk Cartridges) Industry-leading glass cartridges made using FIOLAX® Type I borosilicate glass with high chemical resistance for drug stability. Available in 1–5 ml formats for medical pens, autoinjectors, and dental applications, supplied as bulk non-sterile containers.
- Standard and CosmetiQ Vials (Bulk Vials) Pharmaceutical glass vials made from Type I borosilicate glass, available in two quality levels — Standard and CosmetiQ (tighter cosmetic Acceptable Quality Levels for sensitive or high-value pharmaceuticals). Formats from 2R–100R and 2ml–150ml with high chemical resistance for long-term drug stability.
- Standard Ampoules (Bulk Ampoules) Glass ampoules made using FIOLAX® Type I borosilicate glass with high chemical resistance. Available in 1–30 ml formats with three forms (B, C, D) and three break systems (OPC, CBR, SCO), supplied as bulk non-sterile containers.
- Ampoules Anti-Counterfeiting (AC) Pharmaceutical glass ampoules featuring special ink with light-emitting particles applied as identification rings, OPC dots, or printed text to protect against drug counterfeiting. Available in FIOLAX® clear and amber, 1–30 ml formats in forms B, C, or D.
- Drug Master File (DMF) Regulatory Service Regulatory affairs service providing preparation and registration of Drug Master Files (DMFs) for China, USA, and Canada, with bilingual documentation for China and eCTD format for USA and Canada. Enables pharmaceutical customers to reference SCHOTT containment solutions in drug applications and accelerates regulatory approvals across multiple markets.
Quantifiable outcome
- Over 3 million ampoules used every hour globally
Companies that use Schott
Customer profileSegments2 records
Ideal customer profiles2 records
Schott technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Schott partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- SCHOTT Pharma AG & Co. KGaAcoreSCHOTT Poonawalla is a joint venture partner with SCHOTT Pharma AG & Co. KGaA, Germany (headquartered in Mainz). Established in 1990, SCHOTT Pharma is an international technology group and one of the world's leading experts in glass parenteral packaging. The partnership provides SCHOTT Poonawalla access to SCHOTT Pharma's portfolio of innovations, regulatory expertise, and 7,000+ scientists globally. SCHOTT Poonawalla serves as SCHOTT Pharma's joint venture entity for India's pharmaceutical packaging market.
- AZUR SPACE Solar PowerminorAZUR SPACE Solar Power collaborated with SCHOTT (parent company SCHOTT AG) on the development of SCHOTT® Solar Glass exos, a high-performance cover glass for next-generation space solar cells. The collaboration was supported by funding from the European Space Agency (ESA). This partnership involves SCHOTT AG, not specifically SCHOTT Poonawalla.
- European Space Agency (ESA)minorThe European Space Agency provided funding support for the development of SCHOTT® Solar Glass exos, a high-performance cover glass for space solar cells developed by SCHOTT in collaboration with AZUR SPACE. Note: This is a SCHOTT AG partnership, not SCHOTT Poonawalla specifically.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Schott competitors and assessment
Company assessmentBroad incumbents
- SCHOTT Pharma AG & Co. KGaA: German parent entity and global specialist in pharmaceutical glass packaging producing vials, ampoules, syringes, and cartridges from FIOLAX® tubing. As SCHOTT Poonawalla's parent JV partner, it is the most direct comparable globally with a broader geographic footprint.
- Becton, Dickinson and Company (BD): Global medical technology company with a large pharmaceutical systems segment producing prefilled syringes, vials, and drug delivery devices. A broader incumbent whose Pharmaceutical Systems unit competes directly with SCHOTT Poonawalla in primary injectable containment.
- AptarGroup: Global supplier of dispensing systems, drug delivery, and active material science solutions for pharma, including elastomeric components and prefilled syringe systems. A broader incumbent with overlapping primary packaging/delivery exposure.
- West Pharmaceutical Services: US-based manufacturer of primary packaging and delivery systems for injectable drugs, including stoppers, seals, syringes, and cartridges. Comparable primary containment offering for pharma/biotech customers with broader drug delivery portfolio.
Emerging players
- Corning Incorporated: US-based specialty glass and ceramics manufacturer with Corning Pharmaceutical Technologies producing Valor® glass vials designed to reduce particle contamination and breakage. Competes in premium pharmaceutical glass vials, directly adjacent to SCHOTT Poonawalla's offerings.
Direct peers
- Bormioli Pharma: Italian producer of glass and plastic primary packaging for the pharmaceutical industry, including vials, bottles, ampoules, and syringes. Directly competes with SCHOTT Poonawalla's tubular glass portfolio serving European and global pharma customers.
- Nipro Corporation: Japanese medical device and pharmaceutical packaging manufacturer producing glass vials, ampoules, and prefilled syringes. Operates similar Type I borosilicate glass container lines and serves overlapping pharma and biotech customers globally.
- Gerresheimer AG: German-headquartered global manufacturer of primary packaging glass and plastic containers for pharma, including vials, ampoules, syringes, and cartridges. Directly competes with SCHOTT Poonawalla for the same pharmaceutical and biotech customers with similar tubular glass processing capabilities.
- Stevanato Group: Italian-based provider of pharmaceutical containment solutions including glass vials, syringes, and drug delivery systems. Competes head-to-head with SCHOTT Poonawalla in primary injectable packaging and offers comparable RTU/sterile formats to global pharma customers.
Regional players
- Hindusthan National Glass & Industries (HNG): India's largest glass container manufacturer producing pharmaceutical glass vials, bottles, and ampoules. Indian regional peer with overlapping domestic pharma customer base and similar tubular glass processing capabilities for injectables.
Market position
Strengths5 records
Weaknesses1 record
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Schott social profiles
Digital presenceSchott compliance and trust
Trust signalCompliance14 records
Schott financial estimates
Financial estimateRevenue estimate
Valuation estimate
Schott leadership team
Management profileNumber of profiles
Profiles4 records
Schott funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Schott M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Schott
What does Schott do?
SCHOTT Poonawalla designs and manufactures primary pharmaceutical packaging made from Type I borosilicate glass (FIOLAX®) for injectable drugs, biologics, and vaccines. The portfolio includes ready-to-use (Safepac™) and bulk (StandardLine) vials, prefillable syringes (including dual-chamber), cartridges, and ampoules, complemented by regulatory services such as Drug Master File preparation for China, USA, and Canada.
Is Schott a public or private company?
Schott is a private company. It is classified as corporate owned and is currently operating.
When was Schott founded?
Schott was founded in 1990. It employs 1,001 to 5,000 people.
Where is Schott based?
Schott is headquartered in Mumbai, India, in the Asia region.
How does Schott make money?
Two revenue lines are on record. Pharmaceutical Glass Container Sales are the primary driver. The others are regulatory Services.
Who are Schott's main competitors?
Broad incumbents on record are SCHOTT Pharma AG & Co. KGaA, Becton, Dickinson and Company (BD), AptarGroup and West Pharmaceutical Services. Corning Incorporated is listed as an emerging player. Direct peers are Bormioli Pharma, Nipro Corporation, Gerresheimer AG and Stevanato Group. Hindusthan National Glass & Industries (HNG) is listed as a regional player.
Does Schott have an API?
No public API is recorded for Schott.
What industry is Schott in?
Schott's product category is Pharmaceutical Primary Packaging. Its primary akta.pro industry code is IMALAEAB, Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes), with a secondary code of IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules). Its NAICS code is 327213 and its SIC code is 3221.